Repurposing FDA-approved drugs as NLRP3 inhibitors against inflammatory diseases: machine learning and molecular simulation approaches-Reference-Cited by-同舟云学术

Repurposing FDA-approved drugs as NLRP3 inhibitors against inflammatory diseases: machine learning and molecular simulation approaches

Author:

Agarwal Vipul¹,Haldhar Rajesh²,Hirad Abdurahman Hajinur³,Ahmed Bilal⁴,Han Sang Beom⁵,Gupta Anugya⁶,Raj Vinit⁵,Lee Sangkil⁵

Affiliation:

1. Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Lucknow, Uttar Pradesh, India

2. School of Chemical Engineering, Yeungnam University, Gyeongsan, Republic of Korea

3. Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia

4. Department of Agricultural and Biological Engineering, Purdue University, West Lafayette, Indiana, USA

5. College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea

6. Faculty of Medical and Paramedical Sciences, Madhyanchal Professional University, Bhopal, Madhya Pradesh, India

Funder

King Saud University, Riyadh, Saudi Arabia

National Research Foundation of the Republic of Korea (NRF) funded by the Ministry of Education

Publisher

Informa UK Limited

Link

Reference46 articles.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Correction;Journal of Biomolecular Structure and Dynamics;2024-03-21